Cellular immunotherapy in multiple myeloma.

Cellular immunotherapy in multiple myeloma.
Korean J Intern Med. 2019 Feb 15;:
Authors: Vo MC, Lakshmi TJ, Jung SH, Cho D, Park HS, Chu TH, Lee HJ, Kim HJ, Kim SK, Lee JJ
Abstract
In multiple myeloma (MM), the impaired function of several types of immune cells favors the tumor's escape from immune surveillance and, therefore, its growth and survival. Tremendous improvements have been made in the treatment of MM over the past decade but cellular immunotherapy using dendritic cells, natural killer cells, and genetically engineered T-cells represent a new therapeutic era. The application of these treatments is growing rapidly, based on their capacity to eradicate MM. In this review, we summarize recent progress in cellular immunotherapy for MM and its future prospects.
PMID: 30754964 [PubMed - as supplied by publisher]

Source: The Korean Journal of Internal Medicine - February 15, 2019 Category: Internal Medicine Authors: Vo MC, Lakshmi TJ, Jung SH, Cho D, Park HS, Chu TH, Lee HJ, Kim HJ, Kim SK, Lee JJ Tags: Korean J Intern Med Source Type: research